Former JL MAG Rare Earth CTO and Vice President Kenji Konishi joins EM&T with a team of senior engineers to support expansion toward 10,000 metric tons of annual rare earth magnet capacity ahead of the January 1, 2027 DFARS deadline
Xcellon Biologics Acquires GMP Manufacturing Facility from NextCure, Becoming an End-to-End CRDMO for Next-Generation Bioconjugates and Complex Biologics
Acquisition of the GMP biologics manufacturing facility expands Xcellon’s integrated capabilities from discovery through clinical supply and strengthens U.S. biomanufacturing
Analgesics Market Size Projected to Reach USD 88.85 Billion by 2035 | SNS Insider
The U.S. Analgesics Market is projected to reach USD 30.86 Billion and Europe USD 23.90 Billion by 2035, driven by rising chronic pain and demand for non-opioid therapies.
OZOP Energy Solutions, Inc. Highlights Ballislife Drink’s Partnership with Detroit Pistons Star Jalen Duren
WARWICK, NY, Aug. 10, 2026 (GLOBE NEWSWIRE) — OZOP Energy Solutions, Inc. (OTC: OZSC) today highlighted continued progress within Varon Corp.’s U.S. subsidiary, Varon USA, and its joint venture with Ballislife, Inc. through the addition of another NBA athlete partnership. Ozop and Varon Corp. are currently completing customary pre-closing conditions in connection with the previously announced transaction with OZOP.
Actelis Networks Powers Broadband to Remote Alaska Schools and Healthcare Facilities Through Regional Carrier Orders
Deployment over existing infrastructure delivers reliable and cyber-resilient connectivity in some of the most challenging rural environments in the United States
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award
Recognition honors one of the medical technology industry’s most influential innovators, whose career has helped shape modern cardiovascular care
Schouw & Co. share buy-back programme, week 32 2026
On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026.
Silo Pharma Granted European Patent Covering Novel PTSD Therapy
Patent strengthens global IP protection for novel treatment approach designed to prevent stress-induced psychiatric disorders before symptoms develop
Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO
On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel’s OpenVINO toolkit to accelerate edge inference within healthcare environments
Silo Pharma Granted European Patent Covering Novel PTSD Therapy
Patent strengthens global IP protection for novel treatment approach designed to prevent stress-induced psychiatric disorders before symptoms develop
Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO
On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel’s OpenVINO toolkit to accelerate edge inference within healthcare environments
Ambow Education Holding Ltd. (NYSE American: AMBO) Offers 1,000 Students Free Access to NewSchool’s AI + Design Hybrid Micro-Credential Program
Initiative Delivers on Ambow’s White House Pledge to Expand AI Education Opportunities for America’s Youth
Ambow Education Holding Ltd. (NYSE American: AMBO) Offers 1,000 Students Free Access to NewSchool’s AI + Design Hybrid Micro-Credential Program
Initiative Delivers on Ambow’s White House Pledge to Expand AI Education Opportunities for America’s Youth
Outdoor Holding Company Reports First Quarter Fiscal 2027 Financial Results
Revenue increased 22%, net income from continuing operations increased to $3.6 million, Adjusted EBITDA more than doubled to $7.9 million, and operating cash flow improved by $11.1 million year over year
California Resources Corporation Expands Integrated California Energy Infrastructure Platform Through Strategic Midstream Acquisition
Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader
Establishes an integrated global platform spanning biosimilar R&D, manufacturing and commercialization
IES Holdings to Acquire DBM Global
Transaction Establishes New Structural Line of Business, Adding One of the Largest Independent Structural Steel Fabrication and Erection Platforms in the U.S.
INNOVATE Agrees to $650 Million Sale of DBM Global to IES Holdings
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) — INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that it has entered into a Transaction Agreement (the “Agreement”) pursuant to which IES Holdings, Inc. (Nasdaq: IESC) (“IES”) will acquire DBM Global, Inc. (“DBMG”) for cash and stock consideration valued at $650 million (the “Transaction”). INNOVATE, through DBM Global Intermediate Holdco Inc., currently owns approximately 91.21% of the outstanding common stock of DBMG.